Labcorp study suggests COVID-19 antibodies remain at least 10 months after infection

BURLINGTON, N.C. --(BUSINESS WIRE)--May 24, 2021-- Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals.

Labcorp to expand bioanalytical services with integrated laboratory in Singapore

BURLINGTON, N.C. --(BUSINESS WIRE)--May 19, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore.

A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing

Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity

The impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis